Radboudumc

Running trials

• Recruiting

  A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery.

  NCT07357675· Phase 3· Source

• Not yet recruiting

  A Phase 1/2/3 Study of ATSN-201 Gene Therapy in Subjects with RS1-Associated X linked Retinoschisis

  NCT05878860· Phase 3· Source

• Not yet recruiting

  Preventive Dendritic Cell Vaccination for Lynch Syndrome Carriers

  NCT07609901· Phase 3· Source

• Not yet recruiting

  Preventive Dendritic Cell Vaccination for Lynch Syndrome

  NCT07412197· Phase 1/2· Source

• Recruiting

  Timing of Immunotherapy in Melanoma

  NCT07696715· Source

• Recruiting

  Modafinil for Debilitating Fatigue in Quiescent Inflammatory Bowel Disease MODIFI-IBD Trial)

  NCT07582458· Phase 2/3· Source

• Recruiting

  Promoting Response to IMmunotherapy by Exercise in Patients With Advanced Renal Cell Carcinoma

  NCT07680556· Source

• Not yet recruiting

  Valvosoft Outcomes Registry for Real-World Evidence

  NCT07520591· Source

• Enrolling by invitation

  App-based Protein Support for Older Adults; Coaching Towards Healthy Ageing

  NCT07415408· Source

• Recruiting

  Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi-centre and Multi-modal Approach

  NCT07316296· Phase 3· Source

• Recruiting

  A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack

  NCT07301034· Phase 3· Source

• Recruiting

  A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  NCT07218380· Phase 3· Source

• Recruiting

  Short Course of Radiotherapy Prior to Surgery of Soft Tissue Sarcomas

  NCT07071727· Source

• Recruiting

  LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

  NCT07186101· Phase 2· Source

• Recruiting

  Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical Implementation

  NCT07200466· Source

• Recruiting

  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  NCT07165028· Phase 3· Source

• Recruiting

  PEEP-induced Effects on Respiratory dRivE and EFfort

  NCT07203781· Source

• Recruiting

  Cue2Walk, Cost-effectiveness of Automated Freezing Detection and Provision of External Cues in Comparison to Usual Care in People With Parkinson's Disease

  NCT06416345· Source

• Recruiting

  Prospective Data Collection Initiative on Thoracic Malignancies

  NCT06996249· Source

• Recruiting

  Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  NCT06937086· Phase 3· Source

• Recruiting

  Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  NCT06937099· Phase 3· Source

• Recruiting

  Timely Integration of Palliative Care in Oncology Care for Patients Referred for Palliative Radiotherapy on Bone Metastases: A Randomized Trial

  NCT06805396· Phase 2· Source

• Recruiting

  Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

  NCT06731478· Phase 3· Source

• Recruiting

  A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease

  NCT07363044· Source

• Enrolling by invitation

  Efficacy of Endothelin Receptor Antagonism in Coronary Artery Spasm

  NCT06432452· Phase 2/3· Source

• Active, not recruiting

  Enhancement of Quality of Work And Life

  NCT06573866· Source

• Active, not recruiting

  The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

  NCT06383390· Phase 3· Source

• Recruiting

  The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients

  NCT06082492· Source

• Recruiting

  Vegetarian Diet and Innate Immunity in Patients With Myocardial Infarction and in Healthy Volunteers (FRESH-MI Study)

  NCT06209723· Source

• Recruiting

  Validation of Rapid On-site Diagnostics in Early Stage Lung Cancer Sampling With a Higher Harmonic Generation Microscope

  NCT06007261· Source

• Recruiting

  The Effect of exeRcise And Diet on Quality of Life in Patients With Incurable Cancer of Esophagus and Stomach (RADICES)

  NCT06138223· Source

• Recruiting

  The Effect of Compensation Strategies on Gait Impairment in Parkinson's Disease

  NCT06142448· Source

• Recruiting

  Neural Control of Breathing in Parkinson's Disease

  NCT06074614· Source

• Active, not recruiting

  Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial Haemorrhage

  NCT05986968· Source

• Recruiting

  Observational Dutch Young Symptomatic StrokE studY - nEXT

  NCT05853796· Source

• Not yet recruiting

  Addition of a Focal Boost in External Beam Radiotherapy for Locally Advanced Prostate Cancer by Online Adaptive MR-guided Radiotherapy

  NCT05373316· Phase 2· Source

• Active, not recruiting

  He-move-philia, Lifestyle Intervention for Patients With Hemophilia

  NCT05608863· Source

• Recruiting

  PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer

  NCT03621904· Source

• Recruiting

  Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2

  NCT04628026· Phase 3· Source

• Recruiting

  Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients

  NCT05491200· Phase 4· Source

• Active, not recruiting

  TREAT Study - Improving the Interpretation of Troponin Concentrations Following Exercise and Their Clinical Significance

  NCT06295081· Source

• Recruiting

  A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease

  NCT05478083· Phase 2· Source

• Active, not recruiting

  Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.

  NCT05270044· Phase 3· Source

• Recruiting

  Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study

  NCT05463757· Source

• Active, not recruiting

  Percutaneous Coronary Intervention Before Transcatheter Aortic Valve Implantation

  NCT05078619· Source

• Active, not recruiting

  Short Course Of Preoperative Radiotherapy in Head and Neck-, Trunk- and Extremity Soft Tissue Sarcomas

  NCT04425967· Source

• Recruiting

  Aerobic Fitness or Muscle Mass Training to Improve Colorectal Cancer Outcome

  NCT04754672· Source

• Recruiting

  Distress In CErvical Cancer Patients and Partners

  NCT04475354· Source

• Enrolling by invitation

  The NetherLands Registry of Invasive Coronary Vasomotor Function Testing (NL-CFT)

  NCT06083155· Source

• Active, not recruiting

  Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0

  NCT04045717· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Coronary artery disease6 recruiting
• Parkinson disease4 recruiting
• Crohn's disease3 recruiting
• Lung cancer3 recruiting
• Ulcerative colitis3 recruiting
• Bladder cancer2 recruiting
• Childhood cancers2 recruiting
• Endometrial cancer2 recruiting
• Gastric and esophageal cancer2 recruiting
• Obesity2 recruiting
• Sarcoma2 recruiting
• Acute myeloid leukemia1 recruiting
• Cervical cancer1 recruiting
• Colorectal cancer1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Heart failure1 recruiting
• Kidney cancer1 recruiting
• Melanoma1 recruiting
• Mesothelioma1 recruiting
• Myelodysplastic syndromes1 recruiting
• Ovarian cancer1 recruiting
• Polycystic kidney disease1 recruiting
• Prostate cancer1 recruiting
• Retinitis pigmentosa1 recruiting
• Stroke1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Terminated

  Home Monitoring in Hemophilia A

  NCT06702579· Source

• Completed

  MItochondrial Diabetes LOw Carb- Diet Study

  NCT06185790· Source

• Completed

  Remote 3-week Booster Intervention to Reduce Sedentary Time in Patients With Coronary Artey Disease

  NCT06038188· Source

• Completed

  Study on PhArmacokinetics of First liNe Antiretrovirals in Healthy Breastfeeding Volunteers

  NCT05648201· Phase 4· Source

• Completed

  Therapeutic Drug Monitoring to oPtimize ANtiretroviral regimeNs in HIV-infected Women Who wAnt to Breastfeed

  NCT05642481· Source

• Recruiting

  High-Risk prostatE Cancer radiatiOn Versus surgERy

  NCT05931419· Source

• Completed

  Injection of 99mTc-nanocolloid and ICG to Identify, Retrieve and Qualify TDLN in Early-stage NSCLC

  NCT05555199· Source

• Completed

  The Nijmegen-Leiden-Amsterdam 2-tiered Care Path Study

  NCT05712603· Source

• Completed

  Trained Immunity in Thyroid Carcinoma and Colon Carcinoma

  NCT05280379· Source

• Completed

  Micro-Tech FNB Needle to Obtain Tissue Specimens of Pancreas Malignancy for Personalized Based Chemotherapy

  NCT05249075· Source

• Completed

  Cemiplimab for Secondary Angiosarcomas

  NCT04873375· Phase 2· Source

• Terminated

  GEN1047 for Solid Tumors - First in Human (FIH) Trial

  NCT05180474· Phase 1/2· Source

• Completed

  Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy

  NCT04646005· Phase 2· Source

• Completed

  Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

  NCT04671433· Phase 3· Source

• Completed

  Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis

  NCT04340076· Phase 4· Source

• Terminated

  Cryoballoon Ablation Versus Medical Therapy in Patients With Heart Failure and Atrial Fibrillation

  NCT04342832· Source

• Completed

  Back-to-back Endoscopy Versus Single-pass Endoscopy and Chromoendoscopy in IBD Surveillance

  NCT04291976· Source

• Completed

  Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial

  NCT04099901· Phase 2· Source

• Completed

  A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes

  NCT03914326· Phase 3· Source

• Completed

  Effect of a Reduced Dose Enzalutamide in Frail (m)CRPC Patients on Cognitive Side Effects

  NCT03927391· Phase 4· Source

• Completed

  Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa

  NCT03584165· Phase 3· Source

• Completed

  The TransCatheter Valve and Vessels Trial

  NCT03424941· Source

• Completed

  Experiences and Health-related Quality of Life of Informal Caregivers of Dialysis Patients

  NCT05646615· Source

• Completed

  Melanoma Patients Immunized with Natural DenDritic Cells

  NCT02993315· Phase 3· Source

• Completed

  R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL

  NCT01865110· Phase 3· Source